Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: Involvement in fibrosis and apoptosis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Foster, Cerrone R ^a   Daniel, Laura L ^a   Daniels, Christopher R ^a   Dalal, Suman ^a   Singh, Mahipal ^a   Singh, Krishna ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ALPHA SMOOTH MUSCLE ACTIN; ATM PROTEIN; GELATINASE B; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC REMODELING; CELL ISOLATION; CONTROLLED STUDY; DIASTOLE; FEMALE; FIBROSIS; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HETEROZYGOSITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KNOCKOUT MOUSE; M MODE ECHOCARDIOGRAPHY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SYSTOLE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELLS, CULTURED; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HEART; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; VENTRICULAR REMODELING;

EID: 84892659200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083513     Document Type: Article

References (51)

1. Frantz S, Bauersachs J, Ertl G (2009) Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res 81: 474-481. PubMed: 18977766.
2. Hori M, Nishida K (2009) Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 81: 457-464. PubMed: 19047340.
3. Kempf T, Zarbock A, Vestweber D, Wollert KC (2012) Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing. J Mol Med (Berl) 90: 361-369. doi:10.1007/s00109-011-0847-y. PubMed: 22228177.
4. Li YY, McTiernan CF, Feldman AM (2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46: 214-224. doi:10.1016/S0008- 6363(00)00003-1. PubMed: 10773225.
5. Spinale FG (2002) Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90: 520-530. doi: 10.1161/01.RES.0000013290. 12884.A3. PubMed: 11909815.
6. Abbate A, Narula J (2012) Role of apoptosis in adverse ventricular remodeling. Heart Fail Clin 8: 79-86. doi:10.1016/j.hfc.2011.08.010. PubMed: 22108728.
7. Khanna KK, Lavin MF, Jackson SP, Mulhern TD (2001) ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 8: 1052-1065. doi:10.1038/sj.cdd.4400874. PubMed: 11687884.
8. Lavin MF, Khanna KK, Beamish H, Spring K, Watters D et al. (1995) Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends Biochem Sci 20: 382-383. doi: 10.1016/S0968-0004(00)89083-0. PubMed: 8533147.
9. Su Y, Swift M (2000) Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 133: 770-778. doi: 10.7326/0003-4819-133-10-200011210-00009. PubMed: 11085839.
10. Foster CR, Singh M, Subramanian V, Singh K (2011) Ataxia telangiectasia mutated kinase plays a protective role in beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Mol Cell Biochem 353: 13-22. doi:10.1007/s11010-011-0769-6. PubMed: 21404020.
11. Foster CR, Zha Q, Daniel LL, Singh M, Singh K (2012) Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart: role in beta-adrenergic receptor-stimulated apoptosis. Exp Physiol 97: 506-515. PubMed: 22179422.
12. Yan M, Kuang X, Qiang W, Shen J, Claypool K et al. (2002) Prevention of thymic lymphoma development in Atm-/- mice by dexamethasone. Cancer Res 62: 5153-5157. PubMed: 12234978.
13. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M et al. (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159-171. doi:10.1016/S0092-8674(00)80086-0. PubMed: 8689683.
14. Krishnamurthy P, Subramanian V, Singh M, Singh K (2006) Deficiency of beta1 integrins results in increased myocardial dysfunction after myocardial infarction. Heart 92: 1309-1315. doi:10.1136/hrt.2005.071001. PubMed: 16547211.
15. Krishnamurthy P, Peterson JT, Subramanian V, Singh M, Singh K (2009) Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction. Mol Cell Biochem 322: 53-62. doi:10.1007/s11010-008-9939-6. PubMed: 18979185.
16. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S et al. (2001) Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88: 1080-1087. doi:10.1161/hh1001.090842. PubMed: 11375279.
17. Krishnamurthy P, Subramanian V, Singh M, Singh K (2007) Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension 49: 865-872. doi:10.1161/01.HYP.0000258703. 36986.13. PubMed: 17283249.
18. Daniels CR, Foster CR, Yakoob S, Dalal S, Joyner WL et al. (2012) Exogenous ubiquitin modulates chronic β-adrenergic receptor-stimulated myocardial remodeling: role in Akt activity and matrix metalloproteinase expression. Am J Physiol Heart Circ Physiol 303: H1459-H1468. doi:10.1152/ajpheart.00401.2012.
19. Dalal S, Foster CR, Das BC, Singh M, Singh K (2012) Beta- adrenergicreceptor stimulation induces endoplasmic reticulum stress in adult cardiac myocytes: role in apoptosis. Mol Cell Biochem 364: 59-70.
20. Zakikhani M, Bazile M, Hashemi S, Javeshghani S, Avizonis D et al. (2012) Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin. PLOS ONE 7: e49513. doi:10.1371/journal.pone.0049513. PubMed: 23185347.
21. Chen W, Frangogiannis NG (2013) Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta, 1833: 945-53. PubMed: 22982064 .
22. Frangogiannis NG, Michael LH, Entman ML (2000) Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 48: 89-100. doi: 10.1016/S0008- 6363(00)00158-9. PubMed: 11033111.
23. Willems IE, Havenith MG, De Mey JG, Daemen MJ (1994) The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 145: 868-875. PubMed: 7943177.
24. Greene J, Wang M, Liu YE, Raymond LA, Rosen C et al. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375-30380. doi:10.1074/jbc.271.48.30375. PubMed: 8939999.
25. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677. doi:10.1126/science.281.5383.1674. PubMed: 9733514.
26. Barzilai A, Rotman G, Shiloh Y (2002) ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 1: 3-25. doi:10.1016/S1568-7864(01)00007-6. PubMed: 12509294.
27. Valentin-Vega YA, Maclean KH, Tait-Mulder J, Milasta S, Steeves M et al. (2012) Mitochondrial dysfunction in ataxia-telangiectasia. Blood 119: 1490-1500. doi:10.1182/blood-2011-08-373639. PubMed: 22144182.
28. Lin CS, Wang YC, Huang JL, Hung CC, Chen JY (2012) Autophagy and reactive oxygen species modulate cytotoxicity induced by suppression of ATM kinase activity in head and neck cancer cells. Oral Oncol 48: 1152-1158. doi:10.1016/j.oraloncology.2012.05.020. PubMed: 22763242.
29. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE et al. (1999) Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol 277: H1967-H1974. PubMed: 10564153.
30. Li Y, Takemura G, Okada H, Miyata S, Kanamori H et al. (2007) ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart. Am J Physiol Heart Circ Physiol 292: H946-H953. PubMed: 17028164.
31. Okada H, Takemura G, Kosai K, Li Y, Takahashi T et al. (2005) Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111: 2430-2437. doi: 10.1161/01.CIR.0000165066. 71481.8E. PubMed: 15867170.
32. Chen W, Frangogiannis NG (2010) The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev 15: 415-422. doi:10.1007/s10741-010-9161-y. PubMed: 20213186.
33. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW et al. (1997) Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100: 1363-1372. doi:10.1172/JCI119656. PubMed: 9294101.
34. Colucci WS (1997) Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80: 15L-25L. doi:10.1016/S0002-9149(97)00833-3. PubMed: 9412539.
35. Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110: 159-173. doi:10.1161/CIRCRESAHA.111.243162. PubMed: 22223212.
36. Lovelock JD, Baker AH, Gao F, Dong JF, Bergeron AL et al. (2005) Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. Am J Physiol Heart Circ Physiol 288: H461-H468. PubMed: 15650153.
37. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27: 1281-1292. doi:10.1016/S0022-2828(05)82390-9. PubMed: 8531210.
38. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ (2001) Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89: 201-210. doi:10.1161/hh1501.094396. PubMed: 11485970.
39. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M et al. (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62. doi:10.1172/JCI8768. PubMed: 10880048.
40. Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988. doi:10.1161/01.CIR.101.25.2981. PubMed: 10869273.
41. Tao ZY, Cavasin MA, Yang F, Liu YH, Yang XP (2004) Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci 74: 1561-1572. doi:10.1016/j.lfs.2003.09.042. PubMed: 14729404.
42. Mukherjee R, Snipes JM, Saunders SM, Zavadzkas JA, Spinale FG (2012) Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction. J Surg Res 172: 59-67. doi:10.1016/j.jss.2010.06.015. PubMed: 20863528.
43. Mukherjee R, Mingoia JT, Bruce JA, Austin JS, Stroud RE et al. (2006) Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am J Physiol Heart Circ Physiol 291: H2216-H2228. doi:10.1152/ajpheart.01343.2005. PubMed: 16766634.
44. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S et al. (1989) Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A 86: 8207-8211. doi:10.1073/pnas.86.21.8207. PubMed: 2554304.
45. Mishra PK, Metreveli N, Tyagi SC (2010) MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochem Biophys 57: 67-76. doi:10.1007/s12013-010-9084-1. PubMed: 20422465.
46. Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z (2006) Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle 5: 1940-1945. doi:10.4161/cc.5.17. 3191. PubMed: 16940754.
47. Chen Y, Hou M, Li Y, Traverse JH, Zhang P et al. (2005) Increased superoxide production causes coronary endothelial dysfunction and depressed oxygen consumption in the failing heart. Am J Physiol Heart Circ Physiol 288: H133-H141. PubMed: 15598865.
48. Obal D, Dai S, Keith R, Dimova N, Kingery J et al. (2012) Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Basic Res Cardiol 107: 305. doi:10.1007/s00395-012-0305-1. PubMed: 23099819.
49. Meulmeester E, Jochemsen AG (2008) p53: a guide to apoptosis. Curr Cancer Drug Targets 8: 87-97. doi:10.2174/156800908783769337. PubMed: 18336191.
50. Long X, Goldenthal MJ, Marín-García J (2007) Oxidative stress enhances phosphorylation of p53 in neonatal rat cardiomyocytes. Mol Cell Biochem 303: 167-174. doi:10.1007/s11010-007-9470-1. PubMed: 17457521.
51. Siwik DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ et al. (1999) Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 85: 147-153. doi:10.1161/01.RES.85.2.147. PubMed: 10417396.